Accueil
inhalation
Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems - ScienceDirect

Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems - ScienceDirect

4.5 (351) · € 16.50 · En Stock

Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases

Bioactive natural compounds against human coronaviruses: a review and perspective - ScienceDirect

Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections: Trends in Pharmacological Sciences

The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 - ScienceDirect

Pharmaceutics, Free Full-Text

Therapeutics for COVID-19

Targeted delivery of inhalable drug particles in a patient-specific tracheobronchial tree with moderate COVID-19: A numerical study - ScienceDirect

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet

Targeted pulmonary drug delivery in coronavirus disease (COVID-19) therapy: A patient-specific in silico study based on magnetic nanoparticles-coated microcarriers adhesion - ScienceDirect

Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor

The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment - Clinical Nutrition ESPEN